Clinical Trials Browser

Phase 1 × LB100 × 1 year × Clear all

NCT04560972 2025-11-10

LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer

Phase 1 Active not recruiting

Extensive Stage Lung Small Cell Carcinoma